Back

ChemR23 signalling as a potential therapeutic target in atherosclerosis and cardiovascular diseases

Cardiovascular Research

29 January 2026
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE BASIC SCIENCE
You may be interested in
thumbnail
Congress Presentation
Novel aspects of chemokine receptor signalling in cardiovascular inflammation
21 April 2018
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
17 December 2024
thumbnail
Congress Session
Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation
18 May 2025
thumbnail
Congress Presentation
Olfactory receptor 2 signaling drives experimental abdominal aortic aneurysm formation
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources